Symbol | Exchange | Currency |
|---|
Investing.com - Entera Bio (NASDAQ: ENTX) reported first quarter EPS of $-0.080, $0.06 better than the analyst estimate of $-0.140. Revenue for the quarter came in at $100K versus...
Entera Bio Ltd . (NASDAQ:ENTX) (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today announced feedback from its...
Investing.com - Entera Bio (NASDAQ: ENTX) reported first quarter EPS of $-0.100, $0.02 better than the analyst estimate of $-0.115. Revenue for the quarter came in at $14K versus...
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
| Average | 5.667 (+620.954% Upside) |
| High | 10.000 |
| Low | 2.000 |
| Price | 0.786 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Neutral | Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Neutral | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 88.29 | 89.24 | 88.10 | +0.15 | +0.17% | 12.81M | NYSE | |||
| 125.43 | 126.00 | 123.29 | +1.08 | +0.87% | 25.17M | NASDAQ | |||
| 8.12 | 8.25 | 8.11 | -0.070 | -0.85% | 140.18K | NASDAQ | |||
| 9.00 | 9.00 | 9.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.55 | 0.56 | 0.52 | +0.02 | +3.19% | 49.25K | NYSE | |||
| 16.03 | 16.23 | 15.95 | -0.12 | -0.74% | 1.38M | NYSE | |||
| 2.09 | 2.09 | 2.09 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 18.06 | 18.12 | 18.02 | -0.05 | -0.28% | 10.22M | NASDAQ | |||
| 33.10 | 33.40 | 32.46 | +0.66 | +2.03% | 9.96M | NASDAQ | |||
| 10.28 | 10.40 | 9.84 | +0.50 | +5.11% | 20.39M | NYSE | |||
| 60.10 | 61.72 | 58.88 | +1.02 | +1.73% | 3.91M | NYSE | |||
| 27.56 | 27.74 | 25.87 | +1.67 | +6.45% | 7.19M | NYSE | |||
| 8.38 | 8.41 | 8.30 | +0.040 | +0.48% | 1.15M | NYSE | |||
| 3.38 | 3.99 | 3.31 | -0.67 | -16.54% | 29.14M | NYSE | |||
| 6.57 | 6.70 | 6.13 | +0.28 | +4.37% | 128.48K | NASDAQ |